Articles

Venous thromboembolism in blood or marrow transplant recipients
Epidemiology

Venous thromboembolism in blood or marrow transplant recipients

Cancer is a well-recognized risk factor for venous thromboembolism (VTE) and several risk prediction models have been developed to identify patients at high risk. However, the majority of patients included in these studies had solid tumors, and blood or marrow transplant recipients were excluded...

Read More
VIII Forum of Thrombosis Oncology
News

VIII Forum of Thrombosis Oncology

The VIII Oncology Forum on Thrombosis is going to be held in Madrid, 22-23 February 2019.

Read More
The Pediatric Issue
News

The Pediatric Issue

This special issue of ICTHIC magazine will focus upon challenging issues dealing with children with cancer and thrombosis, the potential role of thrombophilic risk factors and current and future treatments.

Read More
An update on the status of direct oral anticoagulants in children
Trial Update

An update on the status of direct oral anticoagulants in children

Until recently, paediatric investigators focused their efforts on closing the knowledge gap on how to better use classic AC in children.

Read More
The safety of DOACs to treat VTE in patients with brain tumors
Anticoagulation Drugs

The safety of DOACs to treat VTE in patients with brain tumors

Patients with primary and metastatic brain tumors have a high risk of venous thromboembolism, occurring in 20-30% depending on primary tumor type. Anticoagulant therapy for patients with brain tumors is challenging given concerns regarding risk of clinically significant intracranial hemorrhage, which occurs at a rate of between 2-20% in patients not receiving anticoagulation [3-4].

Read More
Arterial thrombosis and pediatric cancer- should cancer associated pediatric stroke be studied?
Epidemiology

Arterial thrombosis and pediatric cancer- should cancer associated pediatric stroke be studied?

While knowledge of arterial thromboembolism prevalence and risk factors among adult cancer patients is currently growing, there seems to be only scarce information regarding arterial thrombosis in general or stroke in particular, among patients and survivors of pediatric cancer.

Read More
Should we test pediatric cancer patients for thrombophilia: NO
How I treat

Should we test pediatric cancer patients for thrombophilia: NO

Cancer is the second most common cause of death in children in developed countries. Fortunately, survival rates have improved enormously over the last decades

Read More
Should we test pediatric cancer patients for thrombophilia: YES
How I treat

Should we test pediatric cancer patients for thrombophilia: YES

Venous thromboembolism in children is a rare disease usually as a secondary complication of primary underlying diseases such as congenital heart disease, sepsis, cancer, or after therapeutic interventions such as central venous lines

Read More
Developmental hemostasis and its relevance to pediatric thrombosis
Epidemiology

Developmental hemostasis and its relevance to pediatric thrombosis

The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in the concentration of the majority of hemostatic proteins between children of different age groups and adults

Read More
Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy
Risk Factors

Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy

Venous thromboembolism is a burdensome and frequent complication in patients with malignancies, especially in those with the most advanced cancer disease.

Read More

Page 1 of 6